News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major headlines released in the past hour, leaving markets without new catalysts.
  • Equity markets traded with low volume and muted price action amid the quiet news flow.
  • Bond yields remained range-bound as investors awaited fresh economic data or central bank signals.
  • Dollar showed little change versus major currencies in absence of policy or data surprises.
  • Oil and commodity prices moved narrowly with traders sidelined ahead of potential supply news.
  • Political and geopolitical developments reported no new disruptions likely to affect markets short-term.

Latest Articles

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

TOMI Environmental Solutions announced new modular integration concepts for its SteraMist iHP platform targeting autonomous vehicles, drone fleets, and robotic systems. The company aims to embed automated disinfection into existing workflows in fleet depots, robotaxi networks, and other autonomous mobility operations to meet growing biosecurity nee…

Celularity Announces Naveen Jain to Join Board of Directors

Celularity Announces Naveen Jain to Join Board of Directors

Celularity Inc., a regenerative medicine company specializing in longevity and cell therapy, announced the appointment of Naveen Jain, founder and CEO of Viome Life Sciences, to its Board of Directors. Jain brings a consumer-focused healthcare perspective and expertise in emerging technologies aimed at personalized health. His addition supports Cel…

SAIC Wins U.S. Customs and Border Protection’s $742 Million Recompete Contract for Traveler and Cargo Security Systems

SAIC Wins U.S. Customs and Border Protection’s $742 Million Recompete Contract for Traveler and Cargo Security Systems

Science Applications International Corp. (SAIC) secured a $742 million recompete contract from U.S. Customs and Border Protection to provide comprehensive support for traveler and cargo security systems. The contract spans five years and reinforces SAIC's role in enhancing U.S. border security through technology integration and system upgrades. Add…

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific highlights progress in building a structured and scalable growth platform for its CompuFlo® medical business. The company is expanding physician adoption through its Advisor Program, securing Medicare reimbursement in key markets, broadening commercial coverage, and building clinical evidence to support broader utilization in m…

U.S. Small Business Employment Rate Remains Steady in September

U.S. Small Business Employment Rate Remains Steady in September

According to Paychex's Small Business Employment Watch, U.S. small business employment rate in September 2026 remained largely stable with a slight increase in the jobs index to 99.15. Wage growth remained moderate, with hourly earnings growth under 3% for over two years, while weekly earnings and hours worked continued to grow, indicating business…

nVent Names Courtney Nelson Wills General Counsel

nVent Names Courtney Nelson Wills General Counsel

nVent Electric plc has appointed Courtney Nelson Wills as Executive Vice President, General Counsel and Secretary effective October 12. Wills brings over 25 years of global legal and governance experience, formerly serving as SVP, General Counsel at MiniMed Group. This strategic hire aims to strengthen nVent's leadership as the company executes its…

Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call

Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call

Axe Compute Inc. announced that since its Q2 earnings call, it has secured over $184 million in customer prepayments and signed more than $266 million in additional AI infrastructure contracts. These developments boost the total contracts signed over the past seven months to over $3.45 billion, reflecting strong demand for its dedicated AI infrastr…

Lite Strategy Reports Fiscal Year 2026 Financial Results

Lite Strategy Reports Fiscal Year 2026 Financial Results

Lite Strategy, Inc. reported fiscal year 2026 financial results highlighting the deployment of $100 million into Litecoin as its primary treasury reserve asset, making it the largest public company holder of LTC. The company initiated a covered call options program generating recurring income and executed a $25 million share repurchase program, sig…

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting

Tarsus Pharmaceuticals announced it will present 11 scientific abstracts at the American Academy of Optometry 2026 Annual Meeting, highlighting new data on Demodex blepharitis, ocular rosacea, and real-world outcomes of its FDA-approved treatment, XDEMVY (lotilaner ophthalmic solution). The presentations aim to deepen clinical understanding and imp…

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

J-Star Holding Co., Ltd., a Nasdaq-listed manufacturer of carbon fiber and composite materials, announced that its Chairman and CEO Jonathan Chiang will relocate full-time to the United States. This move aims to strengthen the company's U.S. presence and accelerate growth by focusing on higher-value applications in healthcare, automotive, aerospace…

Alpha Compute Operating Oil and Gas Assets Due Diligence Estimates 2.9 million barrels of Oil Reserves and $100 million in Natural Gas reserves that can power 200MW for Data Center

Alpha Compute Operating Oil and Gas Assets Due Diligence Estimates 2.9 million barrels of Oil Reserves and $100 million in Natural Gas reserves that can power 200MW for Data Center

Alpha Compute Corp. announced progress on its purchase of oil, gas, and mineral assets in Pennsylvania, estimating 2.9 million barrels of oil in place and significant natural gas reserves capable of powering up to 200 MW for its planned Q1 2028 data center. The acquisition includes more than 75 active oil wells, infrastructure, and surface rights a…

Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.

Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.

Hawkins, Inc. completed the acquisition of Eagle Labs, Inc., enhancing its water treatment distribution and manufacturing capabilities in the Dallas–Fort Worth region. This strategic move extends Hawkins' footprint in Texas to seven water treatment facilities, positioning the company in one of the fastest-growing U.S. metropolitan markets and stren…

Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029

Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029

Tessera Defense and Homeland Security Inc. announced an ambitious financial outlook with a 2027 revenue target of $14-$16 million and a goal of approximately $30 million by 2029, fueled by expansion of its integrated physical security platform across new and existing customers, markets, and acquisitions. The strategy focuses on increasing platform …

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Vor Bio announced positive results from a 48-week post hoc analysis of its Phase 3 trial of telitacicept in generalized myasthenia gravis (gMG). The study demonstrated that telitacicept provides deep and durable symptom relief, with 42% of treated participants achieving minimal symptom expression (MSE) and sustained improvements maintained over the…

Silexion Therapeutics Announces Exercise of Warrants

Silexion Therapeutics Announces Exercise of Warrants

Silexion Therapeutics Corp., a clinical-stage biotech focused on RNAi therapies for KRAS-driven cancers, announced the immediate exercise of outstanding series E warrants to purchase over 3.2 million shares at a reduced price of $0.2603 per share, raising approximately $837,000 before expenses. The company issued new unregistered Series F and G war…

WeShop to Launch in the U.S. November 16: Community-Owned Shopping App Puts Consumers at the Center of a New Model Built Around Rewards, Participation and Ownership

WeShop to Launch in the U.S. November 16: Community-Owned Shopping App Puts Consumers at the Center of a New Model Built Around Rewards, Participation and Ownership

WeShop Holdings Limited (NASDAQ: WSHP), a community-owned shopping platform, announced the launch of its free app in the United States on November 16, 2026. Building on a successful UK pilot that generated £108.5 million in GMV, the app allows members to shop with hundreds of retailers, earn ShareBack rewards in the form of equity, and build owners…

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

argenx SE announced new clinical, long-term, and real-world evidence data on its lead drug VYVGART for treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), along with promising results for pipeline drugs empasiprubart and adimanebart. The data show sustained efficacy, safety, and benefits of earlier treatmen…